<p><h1>Long Acting Drug Delivery Market Growth, Market Trends, COVID-19 Impact, and Forecasts for period from 2024 - 2031</h1></p><p><strong>Long Acting Drug Delivery Market Analysis and Latest Trends</strong></p>
<p><p>Long-acting drug delivery involves the sustained release of medications over an extended period, reducing the frequency of administration and improving patient compliance. This delivery method offers several advantages, including improved therapeutic outcomes, reduced side effects, and convenience for patients. Long-acting drug delivery systems can be designed for different routes, such as injectables, implants, transdermal patches, inhalation, and oral formulations.</p><p>The long-acting drug delivery market is expected to experience significant growth during the forecast period. This growth can be attributed to factors such as the increasing prevalence of chronic diseases, advancements in drug delivery technologies, and the rising demand for patient-centric care. Additionally, the development of novel and innovative drug delivery systems, such as microspheres, lipid-based systems, and nanocarriers, further propels market growth.</p><p>The market is also driven by the growing need for improved drug adherence, particularly in the case of long-term therapies, where frequent dosing may lead to non-compliance. Long-acting drug delivery systems provide a solution by extending drug release and reducing the frequency of administration. This factor is expected to fuel the demand for long-acting drug delivery systems in the coming years.</p><p>Emerging trends in the long-acting drug delivery market include the use of biodegradable materials and smart technologies. Biodegradable materials allow for controlled and predictable drug release, providing safety and efficacy. Smart technologies, such as sensors and microchips embedded in drug delivery systems, enable real-time monitoring of drug release and patient adherence.</p><p>In conclusion, the long-acting drug delivery market is poised for significant growth. Factors such as the increasing prevalence of chronic diseases, advancements in drug delivery technologies, and the need for improved drug adherence contribute to this growth. Furthermore, the adoption of biodegradable materials and smart technologies are emerging trends in the market. The market is anticipated to grow at a CAGR of 12% during the forecast period.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1659703">https://www.reliableresearchreports.com/enquiry/request-sample/1659703</a></p>
<p>&nbsp;</p>
<p><strong>Long Acting Drug Delivery Major Market Players</strong></p>
<p><p>The long-acting drug delivery market has gained significant traction in recent years, attributed to the growing demand for patient-centric treatment options and improved therapeutic outcomes. Some major players in this market include ViiV Healthcare, Halozyme Therapeutics, Lubrizol Life Science, Celanese Corporation, Kashiv BioSciences, 4P Therapeutics, Ipsen, Midatech Pharma, Re-Vana Therapeutics, and Creative Biolabs.</p><p>ViiV Healthcare, a joint venture between GlaxoSmithKline, Pfizer, and Shionogi, focuses on developing and commercializing innovative HIV medicines. The company has witnessed strong growth in recent years, driven by the success of its long-acting HIV treatment, Cabenuva. The market for long-acting HIV drugs is expected to reach $768.2 million by 2026. ViiV Healthcare's robust pipeline and partnerships are poised to drive its future growth in the long-acting drug delivery market.</p><p>Halozyme Therapeutics is a biopharmaceutical company known for its Enhanze drug delivery technology platform. This technology enables the delivery of large molecule therapeutics through subcutaneous injection, improving patient convenience and reducing treatment costs. Halozyme has experienced steady growth, with its revenue increasing from $109.5 million in 2018 to $172.1 million in 2020. The company's strong partnerships with leading pharmaceutical companies and a growing product portfolio bode well for its future growth in the long-acting drug delivery market.</p><p>Kashiv BioSciences, a specialty pharmaceutical company, focuses on developing novel drug delivery systems and complex generics. The company's proprietary technology platforms enable the design and development of long-acting formulations for various therapeutic areas. Kashiv BioSciences has recently raised $207 million in a series C funding round to support the advancement of its pipeline and expand its manufacturing capabilities. With a strong focus on innovation and commercialization, the company is well-positioned for market growth in the long-acting drug delivery space.</p><p>Midatech Pharma is a clinical-stage biotechnology company specializing in the development of drug delivery technologies and oncology treatments. Its Q-Sphera technology allows for sustained release of therapeutics using biocompatible polymer microspheres. The company has a robust portfolio of sustained-release products and a pipeline of potential future therapies. Midatech Pharma reported a 29% increase in its revenue from $3.7 million in 2019 to $4.8 million in 2020, indicating positive market growth and future potential.</p><p>While specific sales revenue figures for these companies may vary, their market growth is evident through their innovative products and technologies, successful clinical trials, strategic partnerships, and investments. As the demand for long-acting drug delivery solutions continues to rise, these companies are poised to capitalize on the market's lucrative opportunities and drive further growth.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Long Acting Drug Delivery Manufacturers?</strong></p>
<p><p>The Long Acting Drug Delivery market is experiencing significant growth due to factors such as the increasing prevalence of chronic diseases, rising demand for effective drug delivery systems, and advances in technology. The market is expected to witness a compound annual growth rate (CAGR) of X% during the forecast period. The future outlook for the market looks promising, with the development of innovative drug delivery techniques such as injectable implants, transdermal patches, and microencapsulation. Additionally, the growing need to enhance patient compliance and reduce healthcare costs will further drive the demand for long acting drug delivery systems in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1659703">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1659703</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Long Acting Drug Delivery Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Device</li><li>Parenteral Injections</li></ul></p>
<p><p>Long-acting drug delivery refers to the administration of medications in a sustained and controlled manner over an extended period of time. The device market involves the development and utilization of specialized systems or devices that can provide prolonged drug release within the body, ensuring optimal therapeutic effects. On the other hand, parenteral injections involve the direct introduction of drugs into the body, bypassing the digestive system. These injections can be designed to release medications slowly and steadily, offering a longer duration of action compared to conventional injections. Both approaches contribute to the advancement of drug delivery technologies and aim to improve patient outcomes.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1659703">https://www.reliableresearchreports.com/purchase/1659703</a></p>
<p>&nbsp;</p>
<p><strong>The Long Acting Drug Delivery Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospital</li><li>Specialty Clinics</li><li>Clinical Research Institutes</li><li>Others</li></ul></p>
<p><p>The long-acting drug delivery market finds applications in various healthcare settings. Hospitals utilize long-acting drug delivery systems to ensure continuous and controlled release of medications for patients. Specialty clinics, catering to specific medical conditions, also benefit from these systems to provide extended drug efficacy. Clinical research institutes use long-acting drug delivery technologies to study drug responses in different patient populations. Additionally, other healthcare facilities such as nursing homes or rehabilitation centers can leverage these systems to enhance patient care and improve treatment outcomes.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Long Acting Drug Delivery Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The long-acting drug delivery market is expected to witness significant growth in multiple regions, including North America (NA), Asia-Pacific (APAC), Europe, the United States (USA), and China. North America is poised to dominate the market, with a projected market share of approximately 40%. This growth can be attributed to the region's well-established healthcare infrastructure, increasing prevalence of chronic diseases, and significant investment in research and development activities. Europe and the United States are anticipated to capture a market share of around 30% each, while APAC and China are expected to account for approximately 20% and 10% of the market share, respectively.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1659703">https://www.reliableresearchreports.com/purchase/1659703</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1659703">https://www.reliableresearchreports.com/enquiry/request-sample/1659703</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>